Julie Errington
Newcastle University(GB)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Retinoids in leukemia and cellular processes, Cancer therapeutics and mechanisms, Drug-Induced Ocular Toxicity, Neuroendocrine Tumor Research Advances
Most-Cited Works
- The impact of p53 status on cellular sensitivity to antifolate drugs.(2001)
- → Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children's Cancer Study Group Study(2005)66 cited
- → Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma(2016)61 cited
- → Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group(2007)58 cited
- Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.(2001)
- → Adaptive Dosing Approaches to the Individualization of 13- Cis -Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma(2012)53 cited
- → Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer(2014)44 cited
- → Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours(2007)40 cited
- → Carboplatin therapeutic monitoring in preterm and full-term neonates(2015)39 cited
- → Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells(2002)36 cited